164
Views
22
CrossRef citations to date
0
Altmetric
Review Article

Influence of Immune Privilege on Ocular Tumor Development

&
Pages 80-90 | Received 09 Dec 2009, Accepted 01 Feb 2010, Published online: 06 Apr 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Rachel R. Caspi. (2013) In This Issue: Immunology of the Eye—Inside and Out. International Reviews of Immunology 32:1, pages 1-3.
Read now

Articles from other publishers (21)

Congcong Yan, Xiaojuan Hu, Xiaoyan Liu, Jingting Zhao, Zhenmin Le, Jiayao Feng, Meng Zhou, Xiaoyin Ma, Qingxiang Zheng & Jie Sun. (2023) Upregulation of SLC12A3 and SLC12A9 Mediated by the HCP5/miR-140-5p Axis Confers Aggressiveness and Unfavorable Prognosis in Uveal Melanoma. Laboratory Investigation 103:3, pages 100022.
Crossref
Zhicheng Liu, Shanshan Li, Shan Huang, Tao Wang & Zhicheng Liu. (2021) N6-Methyladenosine Regulators and Related LncRNAs Are Potential to be Prognostic Markers for Uveal Melanoma and Indicators of Tumor Microenvironment Remodeling. Frontiers in Oncology 11.
Crossref
Huan Luo & Chao Ma. (2020) Identification of prognostic genes in uveal melanoma microenvironment. PLOS ONE 15:11, pages e0242263.
Crossref
Lionel Larribère & Jochen Utikal. (2020) Update on GNA Alterations in Cancer: Implications for Uveal Melanoma Treatment. Cancers 12:6, pages 1524.
Crossref
Yongyun Li, Jiahao Shi, Jie Yang, Shengfang Ge, Jianming Zhang, Renbing Jia & Xianqun Fan. (2020) Uveal melanoma: progress in molecular biology and therapeutics. Therapeutic Advances in Medical Oncology 12, pages 175883592096585.
Crossref
Mithalesh Kumar Singh, Lata Singh, Kunzang Chosdol, Neelam Pushker, Rachna Meel, Sameer Bakhshi, Seema Sen & Seema Kashyap. (2019) Clinicopathological relevance of NFκB1/p50 nuclear immunoreactivity and its relationship with the inflammatory environment of uveal melanoma. Experimental and Molecular Pathology 111, pages 104313.
Crossref
Paola Dall'Ara & Lauretta Turin. (2019) Immunology of the canine eye in health and disease: a concise review. Veterinární medicína 64:1, pages 1-17.
Crossref
Maria Sofia Basile, Emanuela Mazzon, Andrea Russo, Santa Mammana, Antonio Longo, Vincenza Bonfiglio, Matteo Fallico, Rosario Caltabiano, Paolo Fagone, Ferdinando Nicoletti, Teresio Avitabile & Michele Reibaldi. (2019) Differential modulation and prognostic values of immune-escape genes in uveal melanoma. PLOS ONE 14:1, pages e0210276.
Crossref
John J. Park, Russell J. Diefenbach, Anthony M. Joshua, Richard F. Kefford, Matteo S. Carlino & Helen Rizos. (2018) Oncogenic signaling in uveal melanoma. Pigment Cell & Melanoma Research 31:6, pages 661-672.
Crossref
Chaoju Gong, Jie Shen, Zejun Fang, Lei Qiao, Ruifang Feng, Xianmi Lin & Suyan Li. (2018) Abnormally expressed JunB transactivated by IL-6/STAT3 signaling promotes uveal melanoma aggressiveness via epithelial–mesenchymal transition. Bioscience Reports 38:4.
Crossref
Charlotte Pandiani, Guillaume E. Béranger, Justine Leclerc, Robert Ballotti & Corine Bertolotto. (2017) Focus on cutaneous and uveal melanoma specificities. Genes & Development 31:8, pages 724-743.
Crossref
Luke D. Rothermel, Arvind C. Sabesan, Daniel J. Stephens, Smita S. Chandran, Biman C. Paria, Abhishek K. Srivastava, Robert Somerville, John R. Wunderlich, Chyi-Chia R. Lee, Liqiang Xi, Trinh H. Pham, Mark Raffeld, Parthav Jailwala, Manjula Kasoji & Udai S. Kammula. (2016) Identification of an Immunogenic Subset of Metastatic Uveal Melanoma. Clinical Cancer Research 22:9, pages 2237-2249.
Crossref
Y Lazebnik & G E Parris. (2015) Comment on: ‘Guidelines for the use of cell lines in biomedical research’: human-to-human cancer transmission as a laboratory safety concern. British Journal of Cancer 112:12, pages 1976-1977.
Crossref
Jason J. Luke, Pierre L. Triozzi, Kyle C. McKenna, Erwin G. Van Meir, Jeffrey E. Gershenwald, Boris C. Bastian, J. Silvio Gutkind, Anne M. Bowcock, Howard Z. Streicher, Poulam M. Patel, Takami Sato, Jeffery A. Sossman, Mario Sznol, Jack Welch, Magdalena Thurin, Sara Selig, Keith T. Flaherty & Richard D. Carvajal. (2015) Biology of advanced uveal melanoma and next steps for clinical therapeutics. Pigment Cell & Melanoma Research 28:2, pages 135-147.
Crossref
Maxine R. Miller, Jonathan B. Mandell, Kelly M. Beatty, Stephen A.K. Harvey, Michael J. Rizzo, Dana M. Previte, Stephen H. Thorne & Kyle C. McKenna. (2014) Splenectomy Promotes Indirect Elimination of Intraocular Tumors by CD8+ T Cells That Is Associated with IFNγ- and Fas/FasL-Dependent Activation of Intratumoral Macrophages. Cancer Immunology Research 2:12, pages 1175-1185.
Crossref
Kalijn F. Bol, Hanneke W. Mensink, Erik H.J.G. Aarntzen, Gerty Schreibelt, Jan E.E. Keunen, Pierre G. Coulie, Annelies de Klein, Cornelis J.A. Punt, Dion Paridaens, Carl G. Figdor & I. Jolanda M. de Vries. (2014) Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients. American Journal of Ophthalmology 158:5, pages 939-947.e5.
Crossref
Kyle C. McKenna, Kelly M. Beatty, Rebecca C. Scherder, Fuwang Li, Huanbo Liu, Alex F. Chen, Arnab Ghosh & Dennis J. Stuehr. (2013) Ascorbate in Aqueous Humor Augments Nitric Oxide Production by Macrophages. The Journal of Immunology 190:2, pages 556-564.
Crossref
Jose R Conejo-Garcia & Tom-Li Stephen. (2012) Editorial: A clear vision needs some balance. Journal of Leukocyte Biology 92:5, pages 918-920.
Crossref
Tonia Mazzarella, Valeria Cambiaghi, Nathalie Rizzo, Lorenzo Pilla, Danilo Parolini, Elena Orsenigo, Annalisa Colucci, Giulio Modorati, Claudio Doglioni, Giorgio Parmiani & Cristina Maccalli. (2011) Ex vivo enrichment of circulating anti-tumor T cells from both cutaneous and ocular melanoma patients: clinical implications for adoptive cell transfer therapy. Cancer Immunology, Immunotherapy 61:8, pages 1169-1182.
Crossref
Inge H.G. Bronkhorst & Martine J. Jager. (2012) Uveal Melanoma: The Inflammatory Microenvironment. Journal of Innate Immunity 4:5-6, pages 454-462.
Crossref
Michael Campoli & Soldano Ferrone. (2011) HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition. Seminars in Immunopathology 33:4, pages 321-334.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.